Pediatric Nephrology

, Volume 31, Issue 12, pp 2289–2297 | Cite as

Loss of function of NaPiIIa causes nephrocalcinosis and possibly kidney insufficiency

  • Dganit Dinour
  • Miriam Davidovits
  • Liat Ganon
  • Justyna Ruminska
  • Ian C. Forster
  • Nati Hernando
  • Eran Eyal
  • Eli J. Holtzman
  • Carsten A. Wagner
Original Article



Inherited metabolic disorders associated with nephrocalcinosis are rare conditions. The aim of this study was to identify the genetic cause of an Israeli-Arab boy from a consanguineous family with severe nephrocalcinosis and kidney insufficiency.


Clinical and biochemical data of the proband and family members were obtained from both previous and recent medical charts. Genomic DNA was isolated from peripheral blood cells. The coding sequence and splice sites of candidate genes (CYP24A1, CYP27B1, FGF23, KLOTHO, SLC34A3 and SLC34A1) were sequenced directly. Functional studies were performed in Xenopus laevis oocytes and in transfected opossum kidney (OK) cells.


Our patient was identified as having nephrocalcinosis in utero, and at the age of 16.5 years, he had kidney insufficiency but no bone disease. Genetic analysis revealed a novel homozygous missense mutation, Arg215Gln, in SLC34A1, which encodes the renal sodium phosphate cotransporter NaPiIIa. Functional studies of the Arg215Gln mutant revealed reduced transport activity in Xenopus laevis oocytes and increased intracellular cytoplasmic accumulation in OK cells.


Our findings show that dysfunction of the human NaPiIIa causes severe renal calcification that may eventually lead to reduced kidney function, rather than complications of phosphate loss.


NaPiIIa Nephrocalcinosis SLC34A1 mutation Vitamin D 



We thank the patient and his family. This study was supported in part by the Swiss National Science Foundation through the National Center for Competence in Research NCCR Kidney.CH and by the EU FP7 E-rare project “Idiopathic Infantile Hypercalcemia” to C.A. Wagner.

Compliance with ethical standards

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethics statement

The study protocol was approved by the institutional review board of the Chaim Sheba Medical Center, Israel. Informed consent for genetic analysis and medical evaluation was obtained from all subjects studied. Consent of the minors was given by their parents.


  1. 1.
    Edvardsson VO, Goldfarb DS, Lieske JC, Beara-Lasic L, Anglani F, Milliner DS, Palsson R (2013) Hereditary causes of kidney stones and chronic kidney disease. Pediatr Nephrol 28:1923–1942CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, Misselwitz J, Klaus G, Kuwertz-Broking E, Fehrenbach H, Wingen AM, Guran T, Hoenderop JG, Bindels RJ, Prosser DE, Jones G, Konrad M (2011) Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 365:410–421CrossRefPubMedGoogle Scholar
  3. 3.
    Dinour D, Davidovits M, Aviner S, Ganon L, Michael L, Modan-Moses D, Vered I, Bibi H, Frishberg Y, Holtzman EJ (2014) Maternal and infantile hypercalcemia caused by vitamin-D-hydroxylase mutations and vitamin D intake. Pediatr Nephrol 30:145–152CrossRefPubMedGoogle Scholar
  4. 4.
    Wagner CA, Hernando N, Forster IC, Biber J (2014) The SLC34 family of sodium-dependent phosphate transporters. Pflugers Arch 466:139–153CrossRefPubMedGoogle Scholar
  5. 5.
    Iwaki T, Sandoval-Cooper MJ, Tenenhouse HS, Castellino FJ (2008) A missense mutation in the sodium phosphate co-transporter Slc34a1 impairs phosphate homeostasis. J Am Soc Nephrol 19:1753–1762CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Beck L, Karaplis AC, Amizuka N, Hewson AS, Ozawa H, Tenenhouse HS (1998) Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci U S A 95:5372–5377CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Prie D, Huart V, Bakouh N, Planelles G, Dellis O, Gerard B, Hulin P, Benque-Blanchet F, Silve C, Grandchamp B, Friedlander G (2002) Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. N Engl J Med 347:983–991CrossRefPubMedGoogle Scholar
  8. 8.
    Lapointe JY, Tessier J, Paquette Y, Wallendorff B, Coady MJ, Pichette V, Bonnardeaux A (2006) NPT2a gene variation in calcium nephrolithiasis with renal phosphate leak. Kidney Int 69:2261–2267CrossRefPubMedGoogle Scholar
  9. 9.
    Magen D, Berger L, Coady MJ, Ilivitzki A, Militianu D, Tieder M, Selig S, Lapointe JY, Zelikovic I, Skorecki K (2010) A loss-of-function mutation in NaPi-IIa and renal Fanconi’s syndrome. N Engl J Med 362:1102–1109CrossRefPubMedGoogle Scholar
  10. 10.
    Rajagopal A, Braslavsky D, Lu JT, Kleppe S, Clement F, Cassinelli H, Liu DS, Liern JM, Vallejo G, Bergada I, Gibbs RA, Campeau PM, Lee BH (2014) Exome sequencing identifies a novel homozygous mutation in the phosphate transporter SLC34A1 in hypophosphatemia and nephrocalcinosis. J Clin Endocrinol Metab 99:E2451–E2456CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Oddsson A, Sulem P, Helgason H, Edvardsson VO, Thorleifsson G, Sveinbjornsson G, Haraldsdottir E, Eyjolfsson GI, Sigurdardottir O, Olafsson I, Masson G, Holm H, Gudbjartsson DF, Thorsteinsdottir U, Indridason OS, Palsson R, Stefansson K (2015) Common and rare variants associated with kidney stones and biochemical traits. Nat Commun 6:7975CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Halbritter J, Baum M, Hynes AM, Rice SJ, Thwaites DT, Gucev ZS, Fisher B, Spaneas L, Porath JD, Braun DA, Wassner AJ, Nelson CP, Tasic V, Sayer JA, Hildebrandt F (2015) Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol 26:543–551CrossRefPubMedGoogle Scholar
  13. 13.
    Schlingmann KP, Ruminska J, Kaufmann M, Dursun I, Patti M, Kranz B, Pronicka E, Ciara E, Akcay T, Bulus D, Cornelissen EA, Gawlik A, Sikora P, Patzer L, Galiano M, Boyadzhiev V, Dumic M, Vivante A, Kleta R, Dekel B, Levtchenko E, Bindels RJ, Rust S, Forster IC, Hernando N, Jones G, Wagner CA, Konrad M (2015) Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia. J Am Soc Nephrol 27:604–614CrossRefPubMedGoogle Scholar
  14. 14.
    Virkki LV, Forster IC, Hernando N, Biber J, Murer H (2003) Functional characterization of two naturally occurring mutations in the human sodium-phosphate cotransporter type IIa. J Bone Miner Res 18:2135–2141CrossRefPubMedGoogle Scholar
  15. 15.
    Reshkin SJ, Forgo J, Murer H (1990) Functional asymmetry of phosphate transport and its regulation in opossum kidney cells: phosphate transport. Pflugers Arch 416:554–560CrossRefPubMedGoogle Scholar
  16. 16.
    Pfister MF, Lederer E, Forgo J, Ziegler U, Lotscher M, Quabius ES, Biber J, Murer H (1997) Parathyroid hormone-dependent degradation of type II Na+/Pi cotransporters. J Biol Chem 272:20125–20130CrossRefPubMedGoogle Scholar
  17. 17.
    Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang HM, Marth GT, Mcvean GA (2012) An integrated map of genetic variation from 1,092 human genomes. Nature 491:56–65CrossRefPubMedGoogle Scholar
  18. 18.
    Fenollar-Ferrer C, Patti M, Knopfel T, Werner A, Forster IC, Forrest LR (2014) Structural fold and binding sites of the human Na(+)-phosphate cotransporter NaPi-II. Biophys J 106:1268–1279CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Fenollar-Ferrer C, Forster IC, Patti M, Knoepfel T, Werner A, Forrest LR (2015) Identification of the first sodium binding site of the phosphate cotransporter NaPi-IIa (SLC34A1). Biophys J 108:2465–2480CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Levtchenko E, Schoeber J, Jaeken J (2010) Genetic disorders of renal phosphate transport. N Engl J Med 363:1774, author reply 1774–1775CrossRefPubMedGoogle Scholar
  21. 21.
    Kenny J, Lees MM, Drury S, Barnicoat A, Van’t Hoff W, Palmer R, Morrogh D, Waters JJ, Lench NJ, Bockenhauer D (2011) Sotos syndrome, infantile hypercalcemia, and nephrocalcinosis: a contiguous gene syndrome. Pediatr Nephrol 26:1331–1334CrossRefPubMedGoogle Scholar
  22. 22.
    Myakala K, Motta S, Murer H, Wagner CA, Koesters R, Biber J, Hernando N (2014) Renal-specific and inducible depletion of NaPi-IIc/Slc34a3, the cotransporter mutated in HHRH, does not affect phosphate or calcium homeostasis in mice. Am J Physiol Renal Physiol 306:F833–F843CrossRefPubMedGoogle Scholar
  23. 23.
    Friedlander G, Prie D (2010) Genetic disorders of renal phosphate transport—author reply. N Engl J Med 363:1774–1775CrossRefGoogle Scholar

Copyright information

© IPNA 2016

Authors and Affiliations

  1. 1.Department of Nephrology and HypertensionThe Chaim Sheba Medical CenterTel-HashomerIsrael
  2. 2.Institute of Pediatric NephrologySchneider Children’s Medical CenterPetah TiqwaIsrael
  3. 3.Institute of PhysiologyUniversity of ZurichZurichSwitzerland
  4. 4.Cancer Research CenterThe Chaim Sheba Medical CenterTehomerIsrael

Personalised recommendations